科学网 › 标签 › 绝经后妇女

标签: 绝经后妇女

相关帖子	版块	作者	回复/查看	最后发表

没有相关内容

相关日志

绝经后妇女早期乳腺癌研究的化学和药物知识发现: xupeiyang 2010-12-28 10:08; http://arrowsmith.psych.uic.edu/cgi-bin/arrowsmith_uic/edit_b.cgi Start A-Literature C-Literature B-list Filter Literature A-query: early breast cancer C-query: in postmenopausal women The B-list contains title words and phrases (terms) that appeared in both the A and the C literature. 1153 articles appeared in both literatures and were not included in the process of computing the B-list but can be viewed here . The results of this search are saved under id # 30035 and can be accessed from the start page after you leave this session. There are 3092 terms on the current B-list ( 1712 are predicted to be relevant), which is shown ranked according to predicted relevance. The list can be further trimmed down using the filters listed in the left margin. To assess whether there appears to be a biologically significant relationship between the AB and BC literatures for specific B-terms, please select one or more B-terms and then click the button to view the corresponding AB and BC literatures. Use Ctrl to select multiple B-terms. job id # 30035 started Mon Dec 27 21:38:13 2010 Max_citations: 50000 Stoplist: /var/www/html/arrowsmith_uic/data/stopwords_pubmed Ngram_max: 3 30035 Search ARROWSMITH A A_query_raw: early breast cancerMon Dec 27 21:38:29 2010 A query = early breast cancer started Mon Dec 27 21:38:30 2010 A query resulted in 21334 titles 30035 Search ARROWSMITH C C_query_raw: in postmenopausal women Mon Dec 27 21:38:46 2010 C: in postmenopausal women 37080 A: pubmed_query_A 21334 AC: ( early breast cancer ) AND ( in postmenopausal women ) 1153 C query = in postmenopausal women started Mon Dec 27 21:38:47 2010 C query resulted in 37080 titles A AND C query resulted in 1153 titles 23939 B-terms ready on Mon Dec 27 21:44:22 2010 Sem_filter: Chemicals Drugs 3092 B-terms left after filter executed Mon Dec 27 22:17:15 2010 B-list on Mon Dec 27 22:19:26 2010 1 docetaxel 2 gemcitabine 3 vinorelbine 4 zoledronic acid 5 paclitaxel 6 raloxifene 7 epirubicin 8 c erbb-2 9 estrogen receptor modulator 10 letrozole 11 vegf 12 codon polymorphism 13 sentinel lymphadenectomy 14 receptor gene polymorphism 15 igf binding protein 16 toremifene 17 exemestane 18 selective estrogen receptor 19 estrogen progesterone receptor 20 aromatase inhibitor 21 erbb-2 oncoprotein 22 growth factor vegf 23 effect raloxifene 24 cyclin e 25 zoladex 26 arimidex 27 zoledronic acid treatment 28 dose epirubicin 29 mineral density premenopausal 30 igfbp 31 epirubicin cyclophosphamide 32 pamidronate 33 high dose epirubicin 34 role bisphosphonate 35 igf binding 36 proliferation marker 37 tamoxifen prevention 38 contrast enhanced 39 adjuvant tamoxifen 40 oral bisphosphonate 41 parathyroid hormone related 42 cancer xenograft 43 soy intake 44 tamoxifen therapy 45 endothelial growth factor 46 estrogen receptor downregulator 47 marker ca 48 paclitaxel first 49 calcium sensing receptor 50 releasing hormone agonist 51 mrna breast 52 ca cea 53 16alpha hydroxyestrone ratio 54 chromogenic situ hybridization 55 igfbp-3 56 expression estrogen receptor 57 receptor breast cancer 58 estrogen receptor status 59 hormone receptor status 60 tamoxifen breast 61 aromatase inhibitor treatment 62 breast cancer xenograft 63 pegylated liposomal doxorubicin 64 selective estrogen 65 taxotere 66 dom cohort 67 estrogen receptor beta 68 hormone agonist 69 estrogen receptor progesterone 70 tamoxifen breast cancer 71 progesterone receptor status 72 letrozole advanced breast 73 associated tamoxifen 74 tamoxifen endometrial 75 fenretinide 76 progesterone receptor human 77 soy isoflavone 78 goserelin 79 lhrh agonist 80 adjuvant treatment breast 81 versus tamoxifen 82 treated tamoxifen 83 t1 breast 84 adjuvant tamoxifen therapy 85 cox-2 86 aromatase inhibitor therapy 87 tamoxifen treated breast 88 estrogen receptor alpha 89 vegf c 90 progesterone receptor breast 91 steroid receptor expression 92 inhibitor breast cancer 93 cancer tamoxifen 94 igf i igf 95 cyclophosphamide methotrexate 5-fluorouracil 96 growth factor system 97 tamoxifen adjuvant 98 nomegestrol acetate 99 fat breast cancer 100 factor binding protein 101 tamoxifen versus 102 mcf-7 human breast 103 intravenous bisphosphonate 104 inhibitor treatment breast 105 high dose medroxyprogesterone 106 breast cancer uk 107 binding protein-3 108 estrogen regulated gene 109 tamoxifen associated 110 mcf-7 human 111 tamoxifen therapy breast 112 diphosphonate 113 dom project 114 role aromatase 115 adjuvant breast cancer 116 bisphosphonate 117 estrogen receptor breast 118 expression estrogen 119 tamoxifen treated 120 effect adjuvant tamoxifen 121 adjuvant cyclophosphamide methotrexate 122 paclitaxel first line 123 mcf-7 breast cancer 124 tamoxifen treatment breast 125 breast cancer tamoxifen 126 tamoxifen adjuvant therapy 127 mitoxantrone 128 breast cancer adjuvant 129 weekly paclitaxel 130 t1 breast cancer 131 receptor modulator serm 132 2-hydroxyestrone 16alpha hydroxyestrone 133 methotrexate 5-fluorouracil 134 receptor positive breast 135 protein igfbp 136 maspin 137 cyclophosphamide methotrexate 138 response tamoxifen 139 cyclophosphamide methotrexate fluorouracil 140 adjuvant cmf 141 receptor breast 142 receptor progesterone receptor 143 breast cancer co 144 adriamycin cyclophosphamide 145 contraceptive risk 146 matrix metalloproteinase-2 147 tamoxifen treatment 148 menopausal hormone 149 receptor human breast 150 oral contraceptive risk 151 hormone receptor positive 152 methylenetetrahydrofolate reductase polymorphism 153 serum tumor marker 154 tamoxifen aromatase 155 statin 156 receptor modulator 157 receptor primary breast 158 estrogen regulated 159 dose medroxyprogesterone 160 tamoxifen or combination 161 antioestrogen 162 docetaxel treatment 163 mcf-7 164 factor receptor breast 165 goserelin premenopausal 166 progesterone receptor primary 167 risk hormone 168 cyclin d1 169 steroid hormone receptor 170 dose medroxyprogesterone acetate 171 patient tamoxifen 172 trial tamoxifen 173 bisphosphonate treatment 174 methotrexate 5-fluorouracil cmf 175 factor binding protein-3 176 bisphosphonate bone 177 liposomal doxorubicin 178 adjuvant treatment tamoxifen 179 tamoxifen prevention breast 180 gnrh agonist 181 role tamoxifen 182 antiestrogen 183 treated adjuvant tamoxifen 184 soy consumption 185 telomerase activity 186 bisphosphonate therapy 187 mcf-7 cell 188 adjuvant tamoxifen treatment 189 u s preventive 190 mifepristone 191 oral contraceptive breast 192 inhibitor breast 193 25-hydroxyvitamin d 194 versus doxorubicin 195 acid phosphatase 5b 196 adjuvant breast 197 er positive breast 198 anastrozole arimidex 199 contraceptive breast cancer 200 adjuvant breast bowel 201 according estrogen 202 tamoxifen resistance 203 pyridinium crosslink 204 tamoxifen toremifene 205 mineral density breast 206 adjuvant tamoxifen breast 207 antigen ca 208 tacrolimus 209 cancer treated tamoxifen 210 e cadherin 211 following tamoxifen 212 cyclooxygenase-2 213 tumor marker ca 214 tamoxifen women 215 factor receptor estrogen 216 pthrp 217 droloxifene 218 i igf 219 cyclooxygenase-2 expression 220 methylenetetrahydrofolate reductase 221 regulation estrogen receptor 222 selective sentinel 223 mcf-7 breast 224 growth factor binding 225 doxorubicin cyclophosphamide 226 cmf adjuvant 227 treatment aromatase inhibitor 228 proton spectroscopy 229 study docetaxel 230 women estrogen receptor 231 contraceptive hormone replacement 232 alcohol breast 233 cyclophosphamide epirubicin 234 tamoxifen response 235 prognostic value estrogen 236 negative sentinel 237 tamoxifen adjuvant treatment 238 triptorelin 239 vitamin d receptor 240 binding protein-3 risk 241 growth mcf-7 242 aromatase 243 tartrate resistant acid 244 urinary 2-hydroxyestrone 16alpha 245 progesterone receptor expression 246 leptin receptor 247 tumor marker 248 receptor her2 249 tamoxifen hormone 250 estrogen receptor content 251 t-47d 252 positive estrogen 253 estrogen human breast 254 coactivator 255 dose toremifene 256 anthracene induced mammary 257 lhrh analogue 258 liquid chromatography tandem 259 mcf-7 tumor 260 treatment tamoxifen 261 cea tpa 262 estrogen receptor er 263 high dose toremifene 264 chemotherapy tamoxifen 265 i igf binding 266 progesterone receptor 267 tamoxifen 268 dietary genistein 269 surgical adjuvant breast 270 breast tumor xenograft 271 estrogen receptor polymorphism 272 tamoxifen induced 273 estrogen antiestrogen 274 sentinel 275 cancer receiving adjuvant 276 bisphosphonate related 277 desogestrel 278 estrogen progesterone 279 compliance hormone 280 factor i insulin 281 reductase polymorphism 282 dietary fat breast 283 extended adjuvant 284 fluorodeoxyglucose 285 bisphosphonate related osteonecrosis 286 receptor er 287 hormone related protein 288 polymorphism estrogen 289 estrogen receptor gene 290 technetium-99m sestamibi 291 tyrosine kinase inhibitor 292 osteocalcin 293 cancer treated adjuvant 294 ppargamma 295 treatment estrogen receptor 296 estradiol receptor 297 letrozole or 298 estrogen signaling 299 fluorouracil 300 term tamoxifen therapy 301 androgen receptor cag 302 international adjuvant breast 303 i insulin growth 304 cyclophosphamide doxorubicin 305 hormone related 306 effect tamoxifen 307 igfbp-1 308 androgen receptor gene 309 buserelin 310 estrogen hormone replacement 311 cetrorelix 312 epirubicin paclitaxel 313 taking tamoxifen 314 t1-t2 315 patient treated tamoxifen 316 trial doxorubicin 317 telomerase 318 receptor progesterone 319 steroid receptor 320 single nucleotide 321 growth factor breast 322 carcinoma tamoxifen 323 clodronate 324 dmba induced mammary 325 progesterone receptor content 326 estrogen dependent breast 327 metformin 328 node negative estrogen 329 thymidine labeling 330 letrozole or tamoxifen 331 bisphosphonate associated osteonecrosis 332 patient hormone receptor 333 venlafaxine 334 bisphosphonate associated 335 docetaxel combination 336 according estrogen receptor 337 combined tamoxifen 338 correlation estrogen 339 ca repeat 340 e cadherin expression 341 danazol 342 antigen breast 343 receptor negative breast 344 lhrh 345 tamoxifen resistant 346 tamoxifen or 347 positive sentinel 348 hormone responsive breast 349 long term tamoxifen 350 treatment aromatase 351 inflammatory cytokine 352 statin breast 353 soy intake breast 354 cadherin 355 doxorubicin based 356 correlation estrogen receptor 357 pai-1 358 matrix metalloproteinase 359 cyclophosphamide followed 360 tumor xenograft 361 participating dom 362 2-hydroxyestrone 363 irinotecan 364 women tamoxifen 365 megestrol 366 breast adipose tissue 367 i collagen c 368 trial adjuvant tamoxifen 369 adjuvant chemoimmunotherapy 370 methylene diphosphonate 371 luteinizing hormone releasing 372 antigen breast cancer 373 prostate specific antigen 374 aromatase inhibitor letrozole 375 generation aromatase inhibitor 376 beta catenin 377 tamoxifen aminoglutethimide 378 third generation aromatase 379 regulation estrogen 380 trial fenretinide 381 atm gene 382 metalloproteinase-1 383 receptor alpha beta 384 catenin 385 estradiol progesterone 386 lipid apolipoprotein 387 dynamic contrast 388 aromatase expression 389 antigen nipple 390 estrogen responsive 391 estrogen breast 392 proliferation mcf-7 393 antiestrogen tamoxifen 394 binding protein igfbp 395 adjuvant letrozole 396 statin breast cancer 397 letrozole extended adjuvant 398 randomized trial tamoxifen 399 node positive estrogen 400 depot medroxyprogesterone 401 nolvadex 402 ovarian hormone 403 tamoxifen aromatase inhibitor 404 estrogen receptor expression 405 i igf i 406 osteocalcin a 407 receiving tamoxifen 408 oral medroxyprogesterone acetate 409 breast cancer hormone 410 tamoxifen trial 411 oral medroxyprogesterone 412 serum lipid apolipoprotein 413 leuprolide 414 factor i igf 415 estrogen breast cancer 416 or anastrozole 417 modified radical 418 megestrol acetate 419 adjuvant clodronate 420 aspirin nsaid 421 estrogen tamoxifen 422 aminoglutethimide hydrocortisone 423 sirolimus 424 x receptor 425 synuclein gamma 426 sf-36 427 hypoxia inducible factor-1alpha 428 nuclear factor kappab 429 aminoglutethimide 430 estrogen insulin 431 cadherin expression 432 level insulin growth 433 mapk 434 chemotherapy cyclophosphamide 435 cyclin dependent kinase 436 upa pai-1 437 retinoid x receptor 438 depot medroxyprogesterone acetate 439 novel estrogen 440 hormone releasing 441 docetaxel vinorelbine 442 adjuvant hormone 443 igf i 444 receptor polymorphism 445 cell line mcf-7 446 followed paclitaxel 447 oral clodronate 448 leuprorelin 449 paclitaxel induced 450 collagen c 451 aromatase activity 452 lh 453 hormone releasing hormone 454 value estrogen 455 role estrogen receptor 456 tamoxifen case report 457 raloxifene tamoxifen 458 sex steroid receptor 459 matrix metalloproteinase-2 tissue 460 toremifene tamoxifen 461 luteinizing hormone follicle 462 sentinel lymphadenectomy breast 463 oral vinorelbine 464 effect antiestrogen 465 cancer patient tamoxifen 466 anti estrogen 467 estrogen receptor signaling 468 tamoxifen human 469 gonadotropin releasing hormone 470 reproductive hormone 471 amphiregulin 472 tamoxifen expression 473 effect aromatase 474 receptor breast carcinoma 475 lovastatin 476 tgf beta1 477 estrogen receptor antagonist 478 99m tc sestamibi 479 expressing estrogen 480 cyclin 481 cyclin e cdk2 482 adjuvant treatment 483 mucinous 484 serum lipid lipoprotein 485 estrogen receptor human 486 vegf breast 487 neridronate 488 igf 489 receptor estrogen 490 estrogen androgen 491 estrogenic activity 492 gnrh analogue 493 cd4 cd8 494 tamoxifen human breast 495 methotrexate fluorouracil node 496 tamoxifen case 497 women receiving tamoxifen 498 tamoxifen resistant breast 499 d-glucose positron emission 500 value urokinase plasminogen 501 timp-1 502 gonadotrophin 503 mineral density 504 timp-2 505 er pr 506 adjuvant hormone therapy 507 tamoxifen postmenopausal 508 orlistat 509 tamoxifen failure 510 plasminogen activator inhibitor 511 progesterone antagonist 512 htert mrna 513 melatonin breast 514 p27 protein 515 mitogen activated protein 516 gadolinium enhanced 517 gnrh 518 finite element 519 diphosphonate treatment 520 tamoxifen a 521 chemotherapy adjuvant 522 cyclophosphamide epirubicin fluorouracil 523 leuprorelin acetate 524 androgen level 525 factor v leiden 526 oncoprotein 527 dose tamoxifen 528 ifosfamide 529 agonist triptorelin 530 soy protein 531 study toremifene 532 women participating dom 533 therapy hormone receptor 534 clodronate bone 535 expression matrix metalloproteinase-2 536 aromatase inhibitor associated 537 estrogen binding 538 medroxyprogesterone acetate 539 lipid lipoprotein 540 tamoxifen or radiotherapy 541 receptor-2 542 growth estrogen 543 receptor cag repeat 544 estrogen receptor selective 545 significance estrogen 546 breast cancer aminoglutethimide 547 vitamin d metabolism 548 insulin sensitivity 549 alcohol breast cancer 550 resistant acid phosphatase 551 relation estrogen receptor 552 topoisomerase i inhibitor 553 ca cea tpa 554 inhibitor pai-1 555 angiogenic 556 sex hormone binding 557 tamoxifen or combined 558 forkhead 559 antiestrogen ici 560 pathology tamoxifen 561 hormone insulin growth 562 progesterone receptor gene 563 post menopausal hormone 564 estrogen receptor 565 vegf a 566 cisplatin vinorelbine 567 receiving adjuvant tamoxifen 568 proliferation mcf-7 breast 569 denaturing gradient gel 570 medroxyprogesterone 571 synthetic retinoid fenretinide 572 bone alkaline phosphatase 573 protein expression breast 574 mdp 575 estradiol breast 576 effect aromatase inhibitor 577 gonadotropin releasing 578 tamoxifen estrogen 579 18f fluoride 580 pure antiestrogen 581 intraoperative sentinel 582 interleukin-6 583 adjuvant cytotoxic 584 pill breast 585 estrogen progestin 586 androgen estrogen 587 low dose tamoxifen 588 cancer adjuvant chemo 589 methotrexate 5-fluorouracil chemotherapy 590 carcinoembryonic antigen 591 receptor gene cag 592 carcinoembryonic 593 tamoxifen treatment metastatic 594 effect antiestrogen tamoxifen 595 99m tc 596 kinase akt 597 growth factor beta1 598 cancer hormone receptor 599 oral idarubicin 600 fluconazole 601 adjuvant tamoxifen postmenopausal 602 variant luteinizing hormone 603 indicator breast cancer 604 estrogen receptor level 605 gonadotrophin releasing hormone 606 leuprolide acetate 607 hormone binding globulin 608 apolipoprotein 609 cea 610 link breast cancer 611 transforming growth factor 612 tegafur 613 clinical trial tamoxifen 614 immunocytochemical estrogen 615 cross talk estrogen 616 xenograft model 617 androgen breast 618 idarubicin 619 breast cancer mcf-7 620 hormone follicle stimulating 621 cancer mcf-7 cell 622 according hormone 623 anthracene induced 624 benefit adjuvant tamoxifen 625 osteopontin 626 progestogen 627 health initiative hormone 628 vascular cell adhesion 629 calcitonin receptor 630 expression occludin 631 cross sex hormone 632 vegf microvessel density 633 cdna microarray 634 adjuvant tamoxifen or 635 circulating estrogen 636 anastrozole tamoxifen 637 xenograft 638 prognostic value cathepsin 639 doxorubicin 640 tamoxifen impact 641 salivary progesterone 642 estrogen receptor analysis 643 hydroxyproline excretion 644 urokinase plasminogen activator 645 pcna bcl-2 646 serum tartrate resistant 647 hormone profile 648 tamoxifen premenopausal 649 mpa 650 dehydroepiandrosterone sulfate 651 mineral density women 652 kinase signaling 653 estrogen dependent 654 igf-1 655 adjuvant clodronate treatment 656 vegf breast cancer 657 carboplatin 658 adjuvant chemo hormone 659 aromatase overexpression 660 pcna 661 receptor coactivator 662 binding globulin 663 effect estrogen insulin 664 cancer estrogen 665 resistant mcf-7 666 medroxyprogesterone acetate mpa 667 false negative sentinel 668 factor binding protein-1 669 versus estrogen 670 insulin growth factor-1 671 or tamoxifen 672 trial tamoxifen or 673 epirubicin regimen 674 gadolinium 675 cyclin d1 p21 676 contrast enhanced ct 677 breast cancer alcohol 678 fat high carbohydrate 679 significance estrogen receptor 680 tamoxifen operable 681 estradiol breast cancer 682 cancer co operative 683 epirubicin versus 684 fenretinide prevent second 685 delayed adjuvant tamoxifen 686 trial fenretinide prevent 687 tamoxifen exemestane 688 relationship estrogen receptor 689 sulfate dhea 690 immunohistochemical detection estrogen 691 analysis estrogen receptor 692 chemotherapy or tamoxifen 693 ca assay 694 cytokeratin 695 kinase b 696 mammalian target rapamycin 697 antigen nipple aspirate 698 receptor beta 699 cancer hormone 700 matrix metalloproteinase-9 701 growth factor beta 702 angiogenic factor 703 syndecan-1 704 mb-231 breast cancer 705 estrogen metabolizing 706 estrogen receptor messenger 707 paclitaxel followed 708 insulin receptor substrate 709 cancer risk hormone 710 tumor associated antigen 711 salivary cortisol 712 androgen receptor 713 bisphosphonate women 714 prognostic indicator breast 715 il-6 tnf alpha 716 silicone breast 717 tgf 718 treated anthracycline 719 oral contraceptive hormone 720 mda mb-231 breast 721 subcutaneous estradiol 722 necrosis factor receptor 723 women receiving hormone 724 mda mb-231 725 genistein 726 rna human breast 727 novantrone 728 cancer cyclophosphamide methotrexate 729 hormone dependent breast 730 toenail selenium 731 estrogen growth factor 732 breast cancer estrogen 733 aminoglutethimide danazol 734 effect toremifene 735 estrogen insulin growth 736 t polymorphism 737 menopausal estrogen 738 tumor estrogen 739 wnt beta catenin 740 total cholesterol 741 epithelial membrane antigen 742 expression estradiol progesterone 743 gnrh agonist triptorelin 744 tgf beta 745 receptor c erbb-2 746 flow cytometric dna 747 nm23-h1 748 tamoxifen chemotherapy 749 older women estrogen 750 int-5 aromatase 751 methotrexate human breast 752 expressing estrogen receptor 753 versus cyclophosphamide methotrexate 754 recombinant human insulin 755 steroid sulfatase 756 receptor gene 757 sex steroid 758 toll receptor 759 new bisphosphonate 760 methotrexate 5-fluorouracil therapy 761 beta3 integrin 762 releasing hormone gnrh 763 patient hormone 764 complementary alternative 765 il-6 766 cancer tamoxifen treatment 767 d dimer 768 adjuvant anastrozole 769 estrogen action 770 level estrogen 771 breast cancer cyclophosphamide 772 dna ploidy stage 773 tamoxifen female genital 774 resistant estrogen 775 hydroxyestrone 776 cmf tamoxifen 777 cathepsin d 778 mda 779 alternatively spliced 780 16alpha hydroxyestrone 781 hla drb1 782 releasing hormone 783 serum hormone 784 atp cell viability 785 cyclin d1 breast 786 e selectin 787 hormone premenopausal 788 metalloproteinase tissue inhibitor 789 hormone breast cancer 790 serum lipoprotein 791 thymidine labeling index 792 detection estrogen progesterone 793 matrix metalloproteinase tissue 794 experimental model estrogen 795 density united 796 bisantrene 797 anthracycline 798 plasma insulin growth 799 luteinizing hormone 800 bisphosphonate osteonecrosis 801 pill breast cancer 802 inhibition aromatase 803 ca serum 804 related tamoxifen 805 fenretinide breast cancer 806 follow tamoxifen treatment 807 women treated hormone 808 expression vegf 809 salmon calcitonin 810 sex hormone 811 antioxidative enzyme 812 growth factor receptor 813 protein breast cancer 814 plasma insulin 815 testosterone estradiol 816 women hormone receptor 817 cancer risk tamoxifen 818 menopausal status estrogen 819 estrogen progestogen 820 splice 821 compared tamoxifen 822 dobutamine stress 823 breast density united 824 follicle stimulating hormone 825 growth factor expression 826 status estrogen receptor 827 cell estrogen 828 dhea 829 receptor invasive breast 830 analysis estrogen 831 lifetime alcohol 832 protein coupled receptor 833 cad 834 immunocytochemical localization estrogen 835 progestin hormone replacement 836 cytometric analysis dna 837 novel estrogen regulated 838 contraceptive hormone 839 gonadal steroid 840 factor vegf breast 841 brain natriuretic peptide 842 tissue inhibitor 843 vinblastine adriamycin 844 hydrocortisone women 845 role tumor marker 846 estrogen regulation 847 tamoxifen operable breast 848 effect estrogen antiestrogen 849 urinary androgen 850 chemotherapy adjuvant treatment 851 signal regulated kinase 852 25-dihydroxycholecalciferol 853 prednimustine 854 women tamoxifen therapy 855 breast cancer active 856 lh rh 857 tamoxifen high 858 tegafur tamoxifen 859 cyclooxygenase-2 inhibition 860 reverse transcriptase mrna 861 hormone breast 862 antiestrogen binding site 863 role soy 864 insulin sensitizing 865 her-2 neu protein 866 expression cyclooxygenase-2 867 glucocorticoid induced 868 prognostic indicator 869 estrogen biosynthesis 870 5-fluorouracil 871 intervention tamoxifen 872 biomarker oxidative 873 proteasome 874 methotrexate fluorouracil chemotherapy 875 propeptide 876 bone isoenzyme 877 tamoxifen primary 878 protein breast 879 isoflavonoid 880 cyclophosphamide fluorouracil 881 antiestrogen breast cancer 882 silicone gel 883 quantification estrogen 884 tumor estrogen receptor 885 pai-1 upa 886 metalloproteinase-2 tissue inhibitor 887 estrone 888 hormone gnrh agonist 889 cyclin d1 overexpression 890 related protein pthrp 891 response trh 892 estrogenic 893 epidermal growth factor 894 impact tamoxifen 895 mineral density study 896 tamoxifen endometrial cancer 897 estrogen sulfatase 898 oral fluoropyrimidine 899 i collagen 900 soy protein isolate 901 bisphosphonate zoledronic acid 902 tamoxifen tamoxifen 903 study goserelin 904 optimizing adjuvant 905 protein kinase b 906 protein kinase pathway 907 psa 908 binding protein-1 909 plasma prolactin 910 expression estradiol 911 value estrogen receptor 912 regulation toll receptor 913 gonadotropin 914 steroid receptor status 915 growth factor i 916 women hormone 917 variation estrogen progesterone 918 cell nuclear antigen 919 tamoxifen effect 920 combination cisplatin 921 prognostic significance progesterone 922 prolactin estradiol 923 nuclear estrogen 924 soy 925 c polymorphism 926 receptor gene expression 927 cancer taking tamoxifen 928 toremifene metastatic breast 929 mitoxantrone novantrone 930 luteinising hormone releasing 931 hormone dependent mcf-7 932 endocrine therapy hormone 933 glucose homeostasis 934 acetate or tamoxifen 935 adriamycin resistant 936 receptor mcf-7 937 daidzein 938 level insulin 939 il-10 940 prognostic significance estrogen 941 resistant tamoxifen 942 estrogen receptor protein 943 releasing hormone analogue 944 adjuvant chemotherapy cyclophosphamide 945 chemotherapy tauromustine 946 prolactin receptor 947 cpg 948 er pgr 949 hydroxysteroid dehydrogenase breast 950 adhesion molecule-1 951 vitamin d 952 urinary steroid 953 t-47d breast 954 trial cyclophosphamide 955 association cyclin 956 growth factor level 957 staurosporine 958 vitamin d3 959 lipocalin 960 proliferation steroid 961 icam-1 962 goserelin premenopausal women 963 stimulated mcf-7 964 model estrogen 965 medroxyprogesterone acetate hd 966 acetate hd mpa 967 retinoid 968 vitamin k 969 estrogen sex hormone 970 mineral density early 971 effect metformin 972 flutamide 973 receptor immunohistochemistry 974 melatonin catecholamine 975 cancer estrogen progesterone 976 n-3 fatty acid 977 zinc finger protein 978 chemo hormone 979 skeletal alkaline phosphatase 980 anti angiogenic 981 nf kappa b 982 dihydropyrimidine dehydrogenase 983 antigen breast carcinoma 984 green tea 985 detection estrogen 986 fluorouracil doxorubicin cyclophosphamide 987 serum estrogen androgen 988 analysis estrogen progesterone 989 hormone binding 990 role progesterone receptor 991 combination adjuvant chemotherapy 992 menopause estrogen 993 sulfotransferase 994 green tea polyphenol 995 tamoxifen single 996 tamoxifen growth 997 insulin growth factor 998 hydroxyproline creatinine 999 nolvadex adjuvant trial 1000 neu protein 1001 apolipoprotein e 1002 derived nitric oxide 1003 progestin 1004 lysyl oxidase 1005 estrogen receptor assay 1006 dose oral medroxyprogesterone 1007 localization estrogen progesterone 1008 stage estrogen receptor 1009 micronutrient 1010 phase trial cyclophosphamide 1011 dmba 1012 estrogen regulated protein 1013 cyclophosphamide doxorubicin fluorouracil 1014 proliferator activated receptor 1015 stress echocardiography 1016 taxol 1017 antiandrogen 1018 gonadotropin receptor 1019 isoflavone 1020 estrogen profile 1021 bcl 1022 study estrogen 1023 egf receptor 1024 androgen breast cancer 1025 determination estrogen receptor 1026 cholesterol breast cancer 1027 response aromatase 1028 tamoxifen efficacy 1029 urinary estrogen 1030 map kinase 1031 hormone receptor 1032 selectin 1033 factor invasive breast 1034 profile estrogen 1035 matrix metalloproteinase-1 1036 perforin 1037 hydrocortisone women metastatic 1038 combined aminoglutethimide hydrocortisone 1039 peroxisome proliferator activated 1040 gnrh analog 1041 dehydroepiandrosterone sulfate dhea 1042 dydrogesterone 1043 response thyrotropin releasing 1044 growth factor tgf 1045 expression insulin growth 1046 5-fluorouracil chemotherapy 1047 cell adhesion molecule-1 1048 alpha estrogen receptor 1049 status hormone receptor 1050 oophorectomy tamoxifen 1051 activator plasminogen activator 1052 adjuvant tamoxifen operable 1053 estrogen human 1054 study tamoxifen 1055 prolactin response thyrotropin 1056 parathyroid hormone 1057 receptor alpha 1058 tissue inhibitor metalloproteinase 1059 estradiol estrone 1060 lhrh agonist treatment 1061 kinase pathway 1062 relation steroid receptor 1063 injectable contraceptive 1064 autoimmune thyroid 1065 growth factor alpha 1066 estradiol progesterone human 1067 acid phosphatase isoform 1068 cytosol estrogen 1069 chemokine 1070 extended radical 1071 sulfatase 1072 estrogen prolactin 1073 tumor aromatase 1074 atm 1075 interleukin-1beta 1076 releasing hormone estrogen 1077 receptor alpha esr1 1078 therapy hormone responsive 1079 3-t mri 1080 vitamin d3 analog 1081 treatment hormone 1082 cytochrome p450 1a1 1083 tamoxifen beta estradiol 1084 relation estrogen 1085 signaling estrogen 1086 estrogen receptor mcf-7 1087 activated protein kinase 1088 inhibition aromatase activity 1089 estramustine phosphate 1090 significance progesterone receptor 1091 carbohydrate antigen 1092 norplant 1093 matrix metalloproteinase-1 production 1094 action estrogen 1095 retinoblastoma protein 1096 hormone insulin 1097 adriamycin cyclophosphamide or 1098 staurosporine induced 1099 tamoxifen pre 1100 oral contraceptive 1101 alpha estrogen 1102 haemostatic 1103 dna ploidy breast 1104 folate 1105 9-cis retinoic acid 1106 ctx 1107 estrogen post 1108 bisphosphonate osteonecrosis jaw 1109 extended adjuvant endocrine 1110 baseline characteristic 1111 fluoride 1112 estrogen induced 1113 primary care provider 1114 neoadjuvant letrozole 1115 factor receptor 2-positive 1116 nab paclitaxel 1117 inhibitor associated bone 1118 effectiveness analysis adjuvant 1119 cyclophosphamide followed paclitaxel 1120 murine bone 1121 receptor concentration 1122 topoisomerase 1123 effect androgen 1124 aromatase activity human 1125 protein expression 1126 regulated kinase 1127 multiple drug chemotherapy 1128 cyclophosphamide adjuvant chemotherapy 1129 effect oral contraceptive 1130 tamoxifen mastectomy 1131 estrogen tamoxifen treatment 1132 hormone endometrial 1133 adriamycin combination chemotherapy 1134 t-47d breast cancer 1135 combination cyclophosphamide 1136 gonadotropin alpha 1137 dobutamine 1138 gonadotropin alpha fetoprotein 1139 tamoxifen tam 1140 neoadjuvant aromatase inhibitor 1141 dehydrogenase breast cancer 1142 estrogen receptor associated 1143 hepatocyte growth factor 1144 isoenzyme alkaline phosphatase 1145 metalloproteinase 1146 neu protein overexpression 1147 versus epirubicin 1148 effect estradiol 1149 i insulin 1150 lipoprotein 1151 overexpression aromatase 1152 value dna 1153 esterified estrogen 1154 calcitonin 1155 histone acetyltransferase 1156 egf 1157 steroidal antiestrogen 1158 d anderson cancer 1159 menopause hormone 1160 neu oncogene product 1161 women estrogen 1162 thiotepa 1163 progesterone breast cancer 1164 hla g 1165 hydroxyproline creatinine ratio 1166 timp-1 timp-2 1167 25-dihydroxyvitamin d3 receptor 1168 response estrogen 1169 cyclooxygenase 1170 carotenoid alpha tocopherol 1171 warfarin induced 1172 technetium-99m 1173 tryptophan metabolism 1174 chorionic gonadotropin alpha 1175 regulate estrogen receptor 1176 contraceptive pill 1177 change estrogen progesterone 1178 endogenous estrogen receptor 1179 ibandronate prevention 1180 cyclin d1 expression 1181 pai-2 1182 steroid hormone 1183 alkaline phosphatase isoenzyme 1184 indicator primary breast 1185 aryl hydrocarbon receptor 1186 disease hormone 1187 provera 1188 synuclein 1189 polyphenol 1190 relationship estrogen 1191 intronic 1192 localization estrogen 1193 receptor assay 1194 breast cancer link 1195 tamoxifen management 1196 patient estrogen 1197 tenascin 1198 factor receptor 1199 nitric oxide synthase 1200 estrogen receptor effect 1201 estrogen treatment 1202 cortisol dehydroepiandrosterone 1203 tamoxifen patient 1204 expression estrogen regulated 1205 relationship steroid receptor 1206 adjuvant hypofractionated 1207 tamoxifen failed 1208 hemostatic 1209 receptor analysis paraffin 1210 il-1 1211 comparing tamoxifen 1212 chemoattractant protein-1 1213 oh 2-vitamin 1214 octreotide 1215 estrogen metabolite 1216 combined hormone 1217 insulin growth 1218 telomerase reverse transcriptase 1219 t47-d 1220 hydroxysteroid dehydrogenase 1221 clodronate therapy 1222 t q23 1223 serum igf 1224 treatment tamoxifen or 1225 role estrogen 1226 agonist treatment breast 1227 status estrogen 1228 mapk signaling 1229 factor receptor her-2 1230 nitrosomethylurea induced rat 1231 oncogene product 1232 protein overexpression 1233 igf i receptor 1234 effect beta estradiol 1235 pr isoform 1236 link hormone 1237 hormone related cancer 1238 profile estrogen receptor 1239 growth mcf-7 cell 1240 bfgf 1241 neu receptor 1242 receptor estrogen receptor 1243 adjuvant breast project 1244 circulating insulin growth 1245 rural urban 1246 oncogene product p21 1247 diethylstilbestrol revisited 1248 fat suppressed magnetic 1249 cisplatin 1250 17beta hydroxysteroid dehydrogenase 1251 estrogenicity 1252 ki-67 cyclin 1253 receptor related protein 1254 progestin hormone 1255 estrogen proliferation 1256 cancer adjuvant treatment 1257 activated protein 1258 systemic growth hormone 1259 nitrosomethylurea induced 1260 epirubicin treatment 1261 estradiol estrogen receptor 1262 tgf beta receptor 1263 discontinuation tamoxifen 1264 paraffin embedded tissue 1265 anti estrogenic 1266 k current 1267 g protein coupled 1268 oncoprotein expression 1269 estrogen receptor isoform 1270 protein human breast 1271 her2 neu receptor 1272 estrogen receptor mediated 1273 protein kinase signaling 1274 high carbohydrate 1275 tamoxifen steroid 1276 linolenic 1277 study leuprorelin 1278 cathepsin 1279 cyclo oxygenase-2 1280 oxide synthase activity 1281 intravenous clodronate 1282 effect estrogen 1283 cost effectiveness letrozole 1284 free estradiol 1285 estrogen responsive gene 1286 doxorubicin advanced 1287 estradiol induced 1288 androgen 1289 serum estrogen 1290 matrix metalloproteinase-2 mmp-2 1291 american ginseng 1292 sex steroid hormone 1293 endogenous estrogen 1294 codon 1295 progestin regulation 1296 behavioral stress 1297 dehydrogenase breast 1298 egf binding 1299 induced estrogen 1300 estrogen selective 1301 receptor mrna 1302 receptor er alpha 1303 polymorphism dna 1304 bcl-2 protein 1305 growth factor egf 1306 estrogen concentration 1307 non contraceptive 1308 proline rich tyrosine 1309 cdna 1310 dna adduct formation 1311 effect hormone 1312 tgfbeta 1313 nsaid 1314 paraffin embedded 1315 retinoic acid receptor 1316 stimulating hormone 1317 estrogen receptor concentration 1318 estrogen mediated 1319 hydroxyproline 1320 expression induced estrogen 1321 survival estrogen 1322 tpa 1323 troponin 1324 tissue inhibitor metalloproteinase-1 1325 resistance insulin growth 1326 estrogen exposure 1327 hormone dependent cancer 1328 caveolin-1 1329 pro apoptotic 1330 cytokine secretion 1331 soluble tumor necrosis 1332 soy isoflavone genistein 1333 cancer monoclonal antibody 1334 rich tyrosine kinase 1335 tobacco smoke 1336 depo provera 1337 inflammatory cytokine response 1338 kinase inhibitor 1339 transcription factor 1340 protein risk 1341 mcf-7 cell line 1342 melatonin level 1343 heparanase 1344 p53 prb 1345 expression progesterone receptor 1346 factor tgf beta1 1347 fasting insulin 1348 angiotensin receptor 1349 therapy hormone 1350 hormone concentration 1351 expression cathepsin 1352 nitric oxide level 1353 5'-untranslated region 1354 variation estrogen 1355 i receptor 1356 association hormone 1357 melatonin 1358 anti estrogen treatment 1359 trh 1360 cancer xenograft model 1361 expression sex steroid 1362 estrogen biosynthesis human 1363 growth factor patient 1364 adipose tissue 1365 organochlorine compound 1366 plasma carotenoid 1367 oxidative damage 1368 growth hormone insulin 1369 dehydrogenase isoenzyme 1370 concentration estrogen progesterone 1371 estrogen growth 1372 dehydroepiandrosterone 1373 exogenous hormone 1374 plasminogen activator inhibitor-1 1375 cyclophosphamide adjuvant 1376 linolenic acid 1377 molecular mechanism estrogen 1378 sequential estrogen 1379 effect lovastatin 1380 adriamycin 1381 development tamoxifen 1382 retinol binding protein 1383 papillary thyroid 1384 insulin receptor 1385 telomerase activity human 1386 nuclear factor 1387 mrna expression 1388 ca patient 1389 tyrosine kinase 1390 drug breast 1391 cytokine production 1392 receiving aromatase inhibitor 1393 according hormone receptor 1394 factor alpha estrogen 1395 chemoattractant 1396 fluorine-18 1397 derived growth factor 1398 adjuvant 1399 novel estrogen receptor 1400 cyclophosphamide 1401 hormone responsive 1402 cytokine expression 1403 protein mcf-7 1404 thyroid hormone receptor 1405 dna hypermethylation 1406 prognosis estrogen receptor 1407 plasma malondialdehyde 1408 troponin i 1409 level immunoglobulin 1410 human estrogen receptor 1411 carbonic anhydrase ix 1412 chemokine receptor 1413 luteinizing hormone human 1414 clusterin 1415 temporal trend adjuvant 1416 induced proliferation mcf-7 1417 consideration bisphosphonate treatment 1418 extended adjuvant letrozole 1419 predictor response aromatase 1420 igf1 ca repeat 1421 paclitaxel adjuvant chemotherapy 1422 haplotype based analysis 1423 effect zoledronic acid 1424 nsaid breast cancer 1425 stress covary 1426 bisphosphonate reducing 1427 therapy bisphosphonate related 1428 immunohistochemistry chromogenic situ 1429 celecoxib women 1430 hyperplasia adjuvant 1431 phosphorus-31 1432 sex steroid excretion 1433 glucocorticoid receptor 1434 change estrogen 1435 metallothionein 1436 oligonucleotide microarray 1437 inhibitor treatment 1438 bupivacaine 1439 reactive protein nipple 1440 osteonecrosis jaw bisphosphonate 1441 aromatase inhibitor induced 1442 protein nipple aspirate 1443 deliver accelerated partial 1444 anastrozole therapy 1445 epirubicin cyclophosphamide followed 1446 role insulin growth 1447 cancer estrogen receptor 1448 glucocorticoid 1449 plasminogen activator plasminogen 1450 antioxidant 1451 tamoxifen aromatase inhibition 1452 chemotherapy cyclophosphamide mitoxantrone 1453 inhibitor tamoxifen adjuvant 1454 controlled trial letrozole 1455 m d 1456 effect adjuvant 1457 c reactive protein 1458 value ca 1459 alphavbeta3 integrin 1460 steroid sulphatase 1461 hormone dependent 1462 il-8 1463 cisplatin based 1464 hormone premenopausal women 1465 estriol 1466 equol 1467 protein-1 1468 gel breast 1469 ftorafur 1470 effect estrogen receptor 1471 apd 1472 17beta estradiol 17alpha 1473 phosphatase predict 1474 cigarette 1475 treatment estrogen 1476 hormonal cytotoxic 1477 novel progestin 1478 epic 1479 selected estrogen receptor 1480 stage estrogen 1481 mrna protein 1482 helicase 1483 estrogen metabolism 1484 peripheral benzodiazepine receptor 1485 estradiol human breast 1486 17beta estradiol 1487 ca diagnosis 1488 factor tamoxifen response 1489 adjuvant treatment aromatase 1490 mineral density adjuvant 1491 raloxifene circulating 1492 predictive factor tamoxifen 1493 aromatase inhibitor hormonal 1494 first line adjuvant 1495 receptor modulator selective 1496 natriuretic peptide 1497 urban rural 1498 methotrexate 1499 tc 1500 receptor tyrosine kinase 1501 factor insulin growth 1502 prolactin cortisol 1503 mnu 1504 following estrogen 1505 mineral 1506 amp activated protein 1507 kaempferol 1508 benzodiazepine 1509 somatostatin analog 1510 luteinising hormone 1511 antibody breast cancer 1512 concentration estrogen 1513 estrogen independent 1514 estrogen not 1515 steroid excretion 1516 dna content endometrial 1517 phospholipid erythrocyte membrane 1518 soy intervention 1519 adjuvant setting breast 1520 tamoxifen treating 1521 corepressor 1522 d binding protein 1523 excretion estrogen 1524 serum ferritin concentration 1525 estrogen or 1526 alpha difluoromethylornithine 1527 aryl hydrocarbon 1528 arsenic trioxide 1529 tamoxifen hot 1530 impact cyclin e 1531 based study campina 1532 androgenic 1533 cell proliferation steroid 1534 concurrent tamoxifen 1535 progesterone 1536 associated plasma protein 1537 estrogen a 1538 interleukin 1539 lactogenic 1540 inhibit estrogen 1541 interleukin-1 1542 il-6 il-11 1543 procollagen 1544 matrix metalloproteinase activity 1545 dom 1546 tgf beta i 1547 clonidine 1548 effect vitamin d 1549 not cyclin 1550 contraceptive 1551 hormone human 1552 expression tgf beta 1553 anthracene 1554 cell adhesion molecule 1555 crosslink 1556 trefoil 1557 plant based dietary 1558 versus cmf adjuvant 1559 evolution adjuvant 1560 blood insulin 1561 beta endorphin 1562 estrone normal 1563 procoagulant 1564 factor egf receptor 1565 human progesterone receptor 1566 anti estrogen tamoxifen 1567 enzyme breast 1568 receiving hormone 1569 reduction hormone 1570 jun 1571 receptor tumor 1572 new tumor marker 1573 mutagenicity 1574 total antioxidant capacity 1575 estrogen prevent 1576 estradiol-17beta 1577 cancer associated promoter 1578 inhibitor matrix metalloproteinase 1579 glutathione s transferase 1580 beta estradiol 1581 isoenzyme activity 1582 hyaluronan 1583 cyclophosphamide high 1584 expression cathepsin d 1585 growth factor insulin 1586 calcium homeostasis human 1587 somatostatin receptor 1588 bone sialoprotein 1589 catechol estrogen 1590 sodium butyrate 1591 neurokinin-1 1592 regulated estrogen 1593 dietary carbohydrate 1594 prolactin 1595 analysis cytokeratin 1596 d3 estrogen 1597 north central cancer 1598 central cancer treatment 1599 gonadotropin beta 1600 growth hormone igf 1601 expression plasminogen activator 1602 estrogen response 1603 steroid sex hormone 1604 study estrogen receptor 1605 drug chemotherapy 1606 17-beta estradiol 1607 receptor c 1608 assay estrogen 1609 estradiol pellet 1610 receptor international breast 1611 methotrexate fluorouracil tamoxifen 1612 hydroxyestrone ratio premenopausal 1613 tamoxifen breast carcinoma 1614 indication adjuvant treatment 1615 synuclein gamma sncg 1616 exemestane breast cancer 1617 radioiodine 1618 estrogen 1619 influence sex hormone 1620 calcium excretion 1621 estradiol stimulate 1622 receptor signaling 1623 soluble vascular 1624 compared doxorubicin 1625 progesterone estrogen 1626 tissue inhibitor matrix 1627 kinase c 1628 receptor messenger 1629 fibroblast growth factor 1630 beta hydroxysteroid dehydrogenase 1631 gm csf 1632 hormone agonist antagonist 1633 expression calcitonin 1634 exogenous estrogen 1635 protein-7 1636 functional estrogen receptor 1637 glucose transporter 1638 vitamin d binding 1639 benzo a pyrene 1640 inhibition estrogen 1641 steroid sex 1642 growth hormone gh 1643 antagonist ru486 1644 vincristine 1645 gh 1646 scavenger receptor 1647 receptor node metastasis 1648 er 1649 testosterone 1650 combined oral contraceptive 1651 effect soy 1652 endothelin 1653 breast hormone 1654 neurokinin 1655 mb 1656 hpr 1657 cream 1658 cytokine response 1659 bone morphogenetic protein 1660 antiapoptotic 1661 dna adduct 1662 lectin binding 1663 il-12 1664 responsive element 1665 prb 1666 oxide synthase gene 1667 p21-activated kinase 1668 circulating insulin 1669 chorionic gonadotropin receptor 1670 ginseng 1671 associated antigen 1672 women gt 1673 cytochrome p450 1674 vimentin 1675 thyroid stimulating hormone 1676 interleukin-8 1677 receptor dna 1678 murine bone marrow 1679 association cyclin d1 1680 interleukin-7 1681 estrogen sensitive 1682 acid premenopausal 1683 overexpression c 1684 tnf alpha 1685 action tamoxifen 1686 aminolevulinic acid 1687 lipid antioxidant 1688 procollagen i 1689 central cancer 1690 urine estrogen 1691 obesity thyroid 1692 progestin dependent 1693 hormone sensitive 1694 formalin fixed paraffin 1695 role progesterone 1696 serum soluble 1697 estradiol relation 1698 function estrogen receptor 1699 hormone growth factor 1700 contraceptive reproductive 1701 strontium 1702 localization estrogen receptor 1703 fluoride bone 1704 plasminogen activator antigen 1705 tamoxifen steroid hormone 1706 hormone estrogen 1707 tgf alpha 1708 targeted estrogen 1709 effect androgen estrogen 1710 estrogen hormone 1711 retinol 1712 medroxyprogesterone acetate early; 个人分类: 知识发现|3245 次阅读|0 个评论

更多...

帐号		自动登录	找回密码
密码			注册

关闭 安全验证

标签: 绝经后妇女

相关帖子

相关日志

关闭安全验证